Related references
Note: Only part of the references are listed.Discovery of small-molecule enzyme activators by activity-based protein profiling
Bernard P. Kok et al.
NATURE CHEMICAL BIOLOGY (2020)
AMP-activated protein kinase: the current landscape for drug development
Gregory R. Steinberg et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
The chemical diversity and structure-based discovery of allosteric modulators for the PIF-pocket of protein kinase PDK1
Xinyuan Xu et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
Mechanistic enzymology in drug discovery: a fresh perspective
Geoffrey A. Holdgate et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Molecular Mechanisms of Enzyme Activation by Monovalent Cations
David W. Gohara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Discovery of Selective Small-Molecule Activators of a Bacterial Glycoside Hydrolase
John F. Darby et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
A small-molecule mimic of a peptide docking motif inhibits the protein kinase PDK1
T. Justin Rettenmaier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Use of Allosteric Targets in the Discovery of Safer Drugs
Ashok Kumar Grover
MEDICAL PRINCIPLES AND PRACTICE (2013)
Allostery and the Monod-Wyman-Changeux Model After 50 Years
Jean-Pierre Changeux
ANNUAL REVIEW OF BIOPHYSICS, VOL 41 (2012)
2-(3-Oxo-1,3-diphenylpropyl)malonic Acids as Potent Allosteric Ligands of the PIF Pocket of Phosphoinositide-Dependent Kinase-1: Development and Prodrug Concept
Adriana Wilhehm et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Targeting PDK1 in Cancer
C. Raimondi et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Turning a protein kinase on or off from a single allosteric site via disulfide trapping
Jack D. Sadowsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Design and synthesis of benzoazepin-2-one analogs as allosteric binders targeting the PIF pocket of PDK1
Linyi Wei et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Discovery of PDK1 Kinase Inhibitors with a Novel Mechanism of Action by Ultrahigh Throughput Screening
Ekaterina V. Bobkova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Piragliatin (RO4389620), a Novel Glucokinase Activator, Lowers Plasma Glucose Both in the Postabsorptive State and after a Glucose Challenge in Patients with Type 2 Diabetes Mellitus: A Mechanistic Study
Riccardo C. Bonadonna et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Turning enzymes ON with small molecules
Julie A. Zorn et al.
NATURE CHEMICAL BIOLOGY (2010)
3,5-Diphenylpent-2-enoic Acids as Allosteric Activators of the Protein Kinase PDK1: Structure-Activity Relationships and Thermodynamic Characterization of Binding as Paradigms for PIF-Binding Pocket-Targeting Compounds
Adriana Stroba et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1
Valerie Hindie et al.
NATURE CHEMICAL BIOLOGY (2009)
Assessing the potential of glucokinase activators in diabetes therapy
Franz M. Matschinsky
NATURE REVIEWS DRUG DISCOVERY (2009)
Small-Molecule Activators of Insulin-Degrading Enzyme Discovered through High-Throughput Compound Screening
Christelle Cabrol et al.
PLOS ONE (2009)
Development of High-Throughput TR-FRET and AlphaScreen (R) Assays for Identification of Potent Inhibitors of PDK1
Zangwei Xu et al.
JOURNAL OF BIOMOLECULAR SCREENING (2009)
Thienopyridone Drugs Are Selective Activators of AMP-Activated Protein Kinase β1-Containing Complexes
John W. Scott et al.
CHEMISTRY & BIOLOGY (2008)
Glucokinase activators in diabetes management
Matthew Coghlan et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Kinetic analysis of effector modulation of butyrylcholinesterase-catalysed hydrolysis of acetanilides and homologous esters
Patrick Masson et al.
FEBS JOURNAL (2008)
Glucokinase activator PSN-GK1 displays enhanced antihyperglycaemic and insulinotropic actions
M. C. T. Fyfe et al.
DIABETOLOGIA (2007)
Allosteric activation of the protein kinase PDK1 with low molecular weight compounds
Matthias Engel et al.
EMBO JOURNAL (2006)
Role of Na+ and K+ in enzyme function
Michael J. Page et al.
PHYSIOLOGICAL REVIEWS (2006)
Predictive blood glucose lowering efficacy by Glucokinase activators in high fat fed female Zucker rats
G. J. Coope et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome
Barbara Cool et al.
CELL METABOLISM (2006)
A structural perspective on enzymes activated by monovalent cations
E Di Cera
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Pyruvate kinase revisited -: The activating effect of K+
J Oria-Hernández et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A novel glucokinase activator modulates pancreatic islet and hepatocyte function
AM Efanov et al.
ENDOCRINOLOGY (2005)
Phosphoinositide-dependent protein kinase 1, a sensor of protein conformation
RM Biondi
TRENDS IN BIOCHEMICAL SCIENCES (2004)
Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase
K Kamata et al.
STRUCTURE (2004)
Microarrayed compound screening (μARCS) to identify activators and inhibitors of AMP-activated protein kinase
SN Anderson et al.
JOURNAL OF BIOMOLECULAR SCREENING (2004)
Allosteric activators of glucokinase: Potential role in diabetes therapy
J Grimsby et al.
SCIENCE (2003)
Crystal structure of substrate free form of glycerol dehydratase
DI Liao et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2003)
A phosphoserine/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation
M Frödin et al.
EMBO JOURNAL (2002)
High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site
RM Biondi et al.
EMBO JOURNAL (2002)
Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation
J Yang et al.
MOLECULAR CELL (2002)
The second activating glucokinase mutation (A456V) - Implications for glucose homeostasis and diabetes therapy
HBT Christesen et al.
DIABETES (2002)
The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB
RM Biondi et al.
EMBO JOURNAL (2001)
A 3-phosphoinositide-dependent protein kinase-1 (PDK1) docking site is required for the phosphorylation of protein kinase Cζ (PKCζ) and PKC-related kinase 2 by PDK1
A Balendran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Crystal structure of human branched-chain α-ketoacid dehydrogenase and the molecular basis of multienzyme complex deficiency in maple syrup urine disease
A AEvarsson et al.
STRUCTURE (2000)
Identification of a pocket in the PDK1 kinase domain that interacts with PIF and the C-terminal residues of PKA
RM Biondi et al.
EMBO JOURNAL (2000)
Share Paper
